Skip to main content
Fig. 4 | Gut Pathogens

Fig. 4

From: Impact of azithromycin mass drug administration on the antibiotic-resistant gut microbiome in children: a randomized, controlled trial

Fig. 4

Gut microbial composition and antibiotic-resistance profile in children who received azithromycin 6-months or 12–24-months previously. a Principal coordinates analysis (PCoA) of Bray-Curtis dissimilarity between children by time since last azithromycin treatment (12–24 months = green, 6 months = orange). Axes labels indicate the plotted component and percentage variance explained. b Univariate analysis of antibiotic classes with increased evidence of resistance (linear regression coefficient > 0) or decreased evidence of resistance (linear regression coefficient < 0) in children who received azithromycin 6 months previously compared to 1–24 months previously

Back to article page

Gut Pathogens

ISSN: 1757-4749